5-138874406-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_015564.3(LRRTM2):​c.155T>A​(p.Phe52Tyr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

LRRTM2
NM_015564.3 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.09
Variant links:
Genes affected
LRRTM2 (HGNC:19409): (leucine rich repeat transmembrane neuronal 2) Predicted to enable neurexin family protein binding activity. Predicted to be involved in regulation of postsynaptic density assembly. Predicted to act upstream of or within several processes, including long-term synaptic potentiation; negative regulation of receptor internalization; and positive regulation of synapse assembly. Is active in GABA-ergic synapse. Is integral component of postsynaptic specialization membrane. [provided by Alliance of Genome Resources, Apr 2022]
CTNNA1 (HGNC:2509): (catenin alpha 1) This gene encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. The encoded mechanosensing protein contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23227015).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRTM2NM_015564.3 linkc.155T>A p.Phe52Tyr missense_variant Exon 2 of 2 ENST00000274711.7 NP_056379.1 O43300
CTNNA1NM_001903.5 linkc.1063-11806A>T intron_variant Intron 7 of 17 ENST00000302763.12 NP_001894.2 P35221-1A0A384MDY0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRTM2ENST00000274711.7 linkc.155T>A p.Phe52Tyr missense_variant Exon 2 of 2 1 NM_015564.3 ENSP00000274711.5 O43300
CTNNA1ENST00000302763.12 linkc.1063-11806A>T intron_variant Intron 7 of 17 1 NM_001903.5 ENSP00000304669.7 P35221-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 30, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.155T>A (p.F52Y) alteration is located in exon 2 (coding exon 2) of the LRRTM2 gene. This alteration results from a T to A substitution at nucleotide position 155, causing the phenylalanine (F) at amino acid position 52 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.089
T
BayesDel_noAF
Benign
-0.37
CADD
Pathogenic
28
DANN
Benign
0.97
DEOGEN2
Benign
0.069
T
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.67
T
M_CAP
Benign
0.0078
T
MetaRNN
Benign
0.23
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
M
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.20
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.010
D
Polyphen
0.55
P
Vest4
0.32
MutPred
0.62
Gain of phosphorylation at F52 (P = 0.08);
MVP
0.17
MPC
0.51
ClinPred
0.91
D
GERP RS
5.1
Varity_R
0.46
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-138210095; API